SARS-CoV-2 mRNA vaccines have demonstrated high efficacy and immunogenicity, but
limited information is currently available on memory B cell generation and long-term …

Large clinical trials have proven the efficacy of the COVID-19 vaccine, and the number of
studies about the effectiveness rapidly grew in the first half of the year after mass vaccination …

Prioritizing Ontario's long-term care home (LTCH) residents for vaccination against severe
acute respiratory syndrome coronavirus 2 has drastically reduced their disease burden; …

Background The humoral immune response following COVID‐19 vaccination in nursing
home residents is poorly known. A longitudinal study compared levels of IgG antibodies …

There is great hope that vaccination against SARS-CoV-2 will decrease the burden of
COVID-19 on nursing home (NH) residents, who have been significantly affected by this …

Vaccine-induced neutralizing antibodies are key in combating the COVID-19 pandemic.
However, delays of boost immunization due to limited availability of vaccines may leave …

Background: It is not known if widespread vaccination can prevent the spread of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in subpopulations at high risk, like …

Objectives The immunogenicity of the Comirnaty® vaccine against coronavirus disease
2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We …

Methods We conducted weekly searches of one academic literature database (MEDLINE via
PubMed) between February 22 and May 11, 2021, to identify any original research articles …

Objectives The current study was aimed at examining SARS-CoV-2 immune responses
following two doses of Comirnaty® COVID-19 vaccine among elderly people in nursing …